CA-IX specific radiopharmaceuticals for the treatment and imaging of cancer
US8211402B2 · kind B2 · utility
42Cited by
8References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 2009 |
| Grant date | Jul 3, 2012 |
| Priority date | — |
| Expiry date | Jan 4, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F13/005
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound that recognizes and binds to the CA-IX protein has Formula I, II, III, or IV. The compounds may include a radioactive element for radioimaging or therapeutic applications. Thus, pharmaceutical compositions may be prepared with one or more of the compounds of Formula I, II, III, or IV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.